Island Pharmaceuticals granted key patent for ISLA-101 in the United States
- Written by PR Newswire
- Island's lead asset, ISLA-101 granted key patent from United Stated Patent & Trademark Office
- Patent underpins Island's drug repurposing strategy to rapidly and efficiently develop antiviral therapies with a key focus being mosquito borne viral diseases, such as dengue fever.
- Around 390 million people are infected with dengue fever each year[1]...
